Toxicity Comparison Between Hypofractionated Radiotherapy With HDR Brachytherapy Boost Versus Standard Treatment
Active, not recruitingNCT01851018
CHU de Quebec-Universite LavalProstate Cancer
Start: 2012-05-31End: 2025-06-30Target: 30Updated: 2024-03-21